Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2021-03-22
2022-11-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating the Efficacy of Platelet-Rich-Plasma (PRP) for Erectile Dysfunction
NCT06264635
Combined Treatment of Platelet-rich Plasma (PRP) and Low-intensity Extracorporeal Shockwave Therapy (Li-ESWT) on Erectile Dysfunction (ED)
NCT04416802
PRP for the Treatment of Erectile Dysfunction (ED)
NCT04350125
Platelet-rich Plasma (PRP) Injection for Treatment of Erectile Function
NCT04050020
LiST Plus PRP Injection Therapy vs LiST Monotherapy for ED Treatment
NCT05366504
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PRP
PRP injection
PRP
4\~6ml autologous platelet rich plasma injection every 14±2 days for a total of 5 injections.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PRP
4\~6ml autologous platelet rich plasma injection every 14±2 days for a total of 5 injections.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Between 20 and 70 years old
* Sexual dysfunction exists for at least 6 months
* IIEF-5 score 8-2
* Sign an informed consent form
Exclusion Criteria
* Radiation therapy to the pelvic area within 12 months before recruiting
* Cancer
* Nervous system diseases that affect erectile function
* Have any blood disease
* History of coronary artery disease
20 Years
70 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taiwan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
I-Ni Chiang, MD
Role: PRINCIPAL_INVESTIGATOR
Taipei Veteran General hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Taiwan University Hospital
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202008061RIPC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.